Canada vs Mauritania: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Canada
85.0%
in 2025
Mauritania
85.0%
in 2025
Canada rank
96th
Mauritania rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Canada
- Mauritania
How they compare
Canada currently reports 85.0% against 85.0% in Mauritania, a difference of 0.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Canada ahead.
Canada ranks 96th and Mauritania ranks 96th of 194 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 0.0% | 46.0% | Canada |
| 2010s | 76.1% | 43.4% | 32.7% | Canada |
| 2020s | 84.7% | 84.0% | 0.7% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Canada or Mauritania?
- Canada, at 85.0% against 85.0% in Mauritania as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Canada and Mauritania?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Mauritania?
- 18 years are reported by both, from 2008 to 2025.
- How do Canada and Mauritania rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Canada ranks 96th and Mauritania ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.